
Evolutionary model for antibiotic resistance reveals dose timing critical to care
evolutionary modeling
to understand drug resistance. The study uses a "fitness seascape" evolutionary model to predict whether an infection will develop
antibiotic resistance
. It found that inconsistent timing and missing early doses can lead to treatment failure.
Using a form of evolutionary modelling,
Cleveland Clinic
researchers can predict what happens if you miss a dose of antibiotics.
.A team led by Jacob Scott, MD, DPhil., including study first author Eshan King, an MD/PhD student at Case Western Reserve University School of Medicine, is refining models that determine recommended antibiotic doses by incorporating bacterial evolutionary dynamics.
"With the rise of '
superbugs
,' or antibiotic-resistant bacterial infections, the world is reaching a crisis point," says Dr. Scott, the study's senior author. "We've already seen from MRSA what can happen if a bacterium becomes antibiotic-resistant. We need to address the problem before it impacts our ability to use antibiotics in more routine aspects of medical care, like surgery or childbirth."
Doctors typically use guidelines from drug companies to decide medication dosages for their patients. These guidelines rely on equations that describe how antibiotics are absorbed in the body to calculate the smallest effective dose that treats the disease, without letting the diseased area evolve a drug-resistant mutation.
Under Dr. Scott's mentorship, King has been expanding some of these models to better reflect how changes in a medication's concentration in our bloodstream affect treatment resistance.
"Many models assume the environment around a diseased area doesn't change, but the environment of an infection is our own bodies. That's never truly constant," King says. "Our manuscript builds on previous work to account for changes in drug concentration over time within our bodies."
Seascape models are equations that include variables that change over time or space , like drug concentration. This allows investigators like King to study new aspects of antibiotic resistance, like how the timing between doses influences medication levels in diseased areas. King used seascape modeling to simulate the outcomes of hundreds of virtual patients being treated for bacterial infections with IV and oral antibiotics.
"Other models have drug concentration as an input, and evolutionary outcome (treatment resistance) as an output. Instead of testing different drug concentrations in separate patients, our model lets us kind of turn a dial to change concentrations in one patient over time to better reflect how our bodies process drug doses ," Dr. Scott explains.
Before this study, missing a dose or stopping antibiotics treatment early was emphasized as a main contributor to treatment resistance. King was surprised to find simulated patients who developed treatment resistance were taking roughly the same amount of medication as those who successfully eliminated their infection.
Instead of the presence or absence of medication at all, it was the timing of the medication doses that differed between these two groups. The team found that missing or being late with early doses played a bigger role in developing antibiotic resistance than missing or being late with a later dose.
The team tested these findings in the lab by treating bacteria with different antibiotic regimens. The bacteria that received all the recommended dose at the recommended time were unlikely to develop treatment resistance. Similarly, bacteria that were appropriately received the early doses but missed later doses did not develop resistance. In contrast, the bacteria that missed early doses but were appropriately treated later evolved treatment resistance, highlighting a potential mechanism of treatment failure in a patient.
"These results are shaping how I will counsel my patients," King says. "I will emphasize that they really need to be on top of taking their antibiotics at the recommended time intervals, especially at the beginning. If they take the first dose and then miss the second dose and then take the third dose, that might not work out so well. There is a higher likelihood that this treatment will fail, and we will have to try something else."

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)

Business Standard
a day ago
- Business Standard
Eating 50 almonds a day may cut oxidative stress, protect DNA, finds study
Almonds have long been celebrated as a brain and heart-healthy snack, but new research suggests their benefits extend much further. According to the study, eating just over 60 grams—around 45 to 50 almonds—a day could help protect DNA and reduce oxidative stress, the underlying process that accelerates ageing and drives chronic illnesses. The findings are from a study titled ' The impact of almond supplementation on oxidative stress biomarkers: a systematic review and meta-analysis of randomized control trials ', published in Scientific Reports. The review analysed data from over 400 adults across eight clinical studies and found that almonds, when consumed in sufficient amounts, strengthen antioxidant defences and lower key markers of cellular damage. What the study shows Participants who consumed over 60 grams of almonds daily experienced: Reduced oxidative DNA damage, shown by lower levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG). Lower lipid peroxidation, indicated by decreased malondialdehyde (MDA) levels, reflecting less damage to cell membranes. Reduced uric acid (UA) levels, associated with lower inflammation and improved heart health. Increased superoxide dismutase (SOD) activity, a key antioxidant enzyme protecting cells from damage. Smaller doses of almonds (below 60 grams daily) showed little to no significant benefit on these biomarkers. Keeping a check on oxidative stress According to the Cleveland Clinic, oxidative stress is an imbalance between free radicals and antioxidants. Excess free radicals damage essential cell components like fats, proteins and DNA, and are linked to: Higher cancer risk through DNA damage. Plaque build-up in arteries, increasing risk of heart attack. Kidney damage and potential failure requiring dialysis. Neurological diseases such as Alzheimer's, Parkinson's, and multiple sclerosis. Dementia due to neuron loss. Respiratory conditions like asthma and COPD. Chronic inflammation in rheumatoid arthritis. What makes almonds powerful Almonds are rich in: Vitamin E (a-tocopherol) – a potent antioxidant that protects cell membranes. Polyphenols and flavonoids – compounds that combat inflammation and DNA damage. Monounsaturated fats and fibre – beneficial for heart health and digestion. Together, these nutrients improve cholesterol levels, reduce inflammation and, as this study indicates, strengthen the body's antioxidant shield. However, scientists caution that not all studies agree, due to variations in almond type and dosage. Future research is needed to determine the optimal amount and form of almond intake, and to identify which groups may benefit the most from daily consumption. What doctors say "When we talk about 60 gram almonds, it is around 45 to 50 pieces. It is safe to consume, but it is not practically ideal because it has around 400 calories. Consuming such quantity everyday can lead to definite weight gain, digestive discomfort and bloating along with kidney concerns. Besides some people have existing allergies and cannot consume almonds," explained Dr Renuka Dang, dietician with Ujala Cygnus Group of Hospitals. "We do not have to take all our Vitamin E from almonds. We can always replace it with kiwi, mango, peanuts, spinach, broccoli, pumpkin. For polyphenols and flavonoids, we can replace it with herbs, spices, grapes, pomegranate, apple, plums, onions, flax seed, green tea. Magnesium can be obtained through lentils, chickpeas, soybeans, banana, avocado. We can obtain a healthy fats from other nuts, seeds, olives, coconut. So whatever nutrients almond has which supports and protects our DNA can be obtained via alternate foods," added Dr Dang.


NDTV
2 days ago
- NDTV
MIT Scientists Develop Superbug-Killing Antibiotics Using Generative AI
Scientists have developed two potential antibiotics using artificial intelligence (AI) that could kill drug-resistant gonorrhoea and MRSA. Researchers at the Massachusetts Institute of Technology (MIT) used generative AI algorithms to scan through a list of potential molecules to predict which one could work as an antibiotic for the superbugs. AI also helped scientists avoid structures that could be harmful to humans or too similar to existing drugs, according to the study published in the journal Cell. After identifying the molecules, both new antibiotics were able to kill strains of bacteria that are becoming increasingly difficult to treat with existing antibiotics. "We're excited because we show that generative AI can be used to design completely new antibiotics," Professor James Collins, MIT, was quoted as saying by the BBC. "AI can enable us to come up with molecules, cheaply and quickly and in this way, expand our arsenal, and really give us a leg up in the battle of our wits against the genes of superbugs." Overusing antibiotics has helped bacteria evolve to develop mechanisms to dodge the drugs' effects. Subsequently, there has been a shortage of new antibiotics for decades. However, the latest development has given scientists a ray of hope. The researchers behind the discovery stated that AI could start a "second golden age" in antibiotic discovery. The breakthrough addresses the growing global public health crisis of antimicrobial resistance, which is responsible for over one million deaths annually. Previous instance In May, a team from the US, UK and Switzerland announced they had developed an AI test that can predict which men with prostate cancer will benefit most from a drug that reduces the risk of dying. The test uses AI to study images of tumours and examine features invisible to the human eye. The team trialled the test on biopsy images from more than 1,000 men with high-risk prostate cancer that had not spread. "The natural history of advanced and aggressive prostate cancer is highly variable and now with better treatments, the risk of cancer relapse can be significantly reduced," said Professor Gert Attard, co-lead of the study. "This study shows, in a very large cohort of patients, that novel AI algorithms can be used to extract information from routinely available pathology slides to tailor these treatments to specific patients and minimise overtreatment whilst maximising the chance of cure."


NDTV
3 days ago
- NDTV
Fitness Enthusiasts Warned in US, UK After Rise In Superbug Infections
A recent UK Health Security Agency (UKHSA) report highlights the growing concern of MRSA superbugs spreading in community settings, particularly in gyms and health clubs, according to The Times. A similar trend has also been reported in the United States, with experts warning against sharing personal items like towels or razors that may come into contact with infected skin or blood. MRSA (methicillin-resistant Staphylococcus aureus) is a type of bacteria resistant to several antibiotics, making infections difficult to treat. MRSA cases are increasingly found outside hospitals, with gyms being a significant source of transmission. The officials are closely monitoring the situation, with locals in the United Kingdom being urged to avoid sharing personal items. According to the report, a total of 175 people were infected outside of hospitals, up 47 per cent from 119 community-onset cases in the same period in 2019, The Independent reported. The bacteria can spread through skin-to-skin contact or contaminated surfaces and equipment. Poor hygiene practices, such as not cleaning equipment or not showering after workouts, can increase the risk of transmission. Colin Brown, a director of antimicrobial assistance and healthcare-related infections at the UKSHA, told The Times, "The overall risk of MRSA bloodstream infections to the public in hospital and community settings remains low [and] substantially below the last peak observed in the early 2000s." "It is too early to conclude whether the current rise represents a sustained shift; however, the trend is being monitored closely through surveillance and analysis to better understand the underlying drivers. This will include further analysis of patient characteristics, such as residential type. "Outbreaks of these infections in community settings can be managed through maintaining good general hygiene, including regular handwashing and not sharing items such as towels and razors." As per UKHSA data published last month, the infection rates increased by 4.1 per cent in the first three months of 2025 compared with the same period last year. Meanwhile, a rise of 39.4 per cent as compared with the same quarter of 2019. As per Andrew Edwards, who is the associate professor of molecular biology at Imperial College London, younger patients who catch it outside of hospitals are often on sports teams or gym users. "We need to keep a very close eye on whether we are seeing a lot more community transition of MRSA between otherwise healthy people ... and watch to see whether this is a blip in the numbers or the beginning of a worrying new trend," he said. While urging gym users, he said, "Check yourself carefully and be aware you might have abrasions that are not immediately obvious. If you do have any, cover those and just be aware." Cases in the US Simon Clarke, of the University of Reading, said cases were "creeping up but... not exploding". He said historically S. aureus was "considered a hospital pathogen and only infected sick people, old people. But it is now more likely to be able to infect younger, fitter people. This bug has evolved. No question about it." Of potential transmission in gyms, he said: "It's a possibility. However, nobody's ever done any real, proper epidemiological studies on this, or gone and swabbed things in gym equipment." Earlier this year, in the summer, a warning had been issued in the US over MRSA being spread in gyms and changing rooms. The authorities in the UK do not record where patients contracted the bug outside of hospitals. Meanwhile, officials from the US Centres for Disease Control and Prevention (CDC) said: "MRSA spreads fast in athletic facilities, locker rooms, gyms and health clubs because of shared equipment and skin-to-skin contact."